Journal of Pathology and Translational Medicine10.4132/jptm.2016.10.182017514441-443Metastatic Squamous Cell Carcinoma from Lung Adenocarcinoma after Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor TherapyHyung Kyu Park, Youjeong Seo, Yoon-La Choi, Myung-Ju Ahn, Joungho Han,,
Clinical Lung Cancer10.3816/clc.2006.s.01120068S31-S35Interstitial Lung Disease Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Non–Small-Cell Lung CarcinomaKen Y. Yoneda, Kimberly A. Hardin, David R. Gandara, David K. Shelton,
Cytopathology10.1111/cyt.128132020313232-235Squamous cell carcinoma transformation of lung adenocarcinoma after tyrosine kinase inhibitor therapy: Cytological approachAlexandra Grosse, Claudia Grosse,,,
Clinical Lung Cancer10.1016/j.cllc.2014.11.0022015163228-236Survival Outcome Assessed According to Tumor Burden and Progression Patterns in Patients With Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Undergoing Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor TherapyYoon Ki Cha, Ho Yun Lee, Myung-Ju Ahn, Yoon-La Choi, Ji Hyun Lee, Keunchil Park, Kyung Soo Lee,
Cancer Research and Treatment10.4143/crt.2013.45.2.79201345279-85Treatment of Non-small Cell Lung Carcinoma after Failure of Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorJae Cheol Lee, Seung Hun Jang, Kye Young Lee, Young-Chul Kim,
Lung Cancer10.1016/j.lungcan.2011.08.0082011742349-351Successful pregnancy with epidermal growth factor receptor tyrosine kinase inhibitor treatment of metastatic lung adenocarcinoma presenting with respiratory failureChee-Hong Lee, Chong-Kin Liam, Yong-Kek Pang, Keong-Tiong Chua, Boon-Khaw Lim, Nai-Lang Lai,
Journal of Thoracic Oncology10.1016/j.jtho.2018.05.02120181310e209-e210Pseudoprogression and Rapid Response to Pembrolizumab in a Patient with Advanced Lung Adenocarcinoma with Loss of Epidermal Growth Factor Receptor Gene Mutation after Tyrosine Kinase Inhibitor TherapyTakumi Yamaura, Hiroyuki Suzuki,
Journal of Thoracic Oncology10.1016/j.jtho.2018.08.59220181310S474P1.01-36 Thoracic Surgery in Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutant After Tyrosine Kinase Inhibitor TherapyC. Hsiao, S. Kuo, K. Chen, J. Chen,
Lung Cancer10.1016/s0169-5002(15)50075-5201587S3076: Patterns of extra-cranial disease progression in epidermal growth factor receptor (EGFR) mutant metastatic non-small cell lung cancer (NSCLC) patients on a tyrosine kinase inhibitor (TKI)K. Aitken, S. Popat, C. Nutting, F. McDonald,
Cancers10.3390/cancers140306862022143686Fluorescence Imaging of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small Cell Lung CancerMarisa L. Martin-Fernandez